Hydrocodone News and Research

RSS
Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Opioids could be dangerous, deadly at high doses

Opioids could be dangerous, deadly at high doses

FDA announces required class-wide safety labeling changes for IR opioid pain medications

FDA announces required class-wide safety labeling changes for IR opioid pain medications

Japanese bioengineers tweak E. coli genes to pump out morphine precursor

Japanese bioengineers tweak E. coli genes to pump out morphine precursor

Long-term use of opioids increases risk of new-onset depression

Long-term use of opioids increases risk of new-onset depression

New data shows opioid overdose deaths hit record levels in 2014

New data shows opioid overdose deaths hit record levels in 2014

Drug use remains stable among teens, MTF survey shows

Drug use remains stable among teens, MTF survey shows

Stanford study finds that overprescription of opioids goes beyond ‘pill mill’ prescribers

Stanford study finds that overprescription of opioids goes beyond ‘pill mill’ prescribers

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

Medical researchers use social media to study harmful side effects of narcotics medication

Medical researchers use social media to study harmful side effects of narcotics medication

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Tris Pharma announces launch of generic TUSSIONEX

Tris Pharma announces launch of generic TUSSIONEX

FDA accepts Braeburn's resubmission of Probuphine NDA for review

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Opioids produced by yeast; revealing the potential for cheaper pain relief

Opioids produced by yeast; revealing the potential for cheaper pain relief

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

Veterans who died from drug overdoses also prescribed benzodiazepines for pain

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction

BioDelivery Sciences calls for new treatment options for opioid addiction